FDA Asks for More Data on Ide-cel as Potential Multiple Myeloma Therapy
The U.S. Food and Drug Administration (FDA) asked…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreThe U.S. Food and Drug Administration (FDA) asked…
A new technology that measures the levels of proteins…
The U.S. Food and Drug Administration (FDA) approved…
Actemra (tocilizumab), a medicine approved for certain…
FFF Enterprises and Bionews announced today that both rare…
While there are few silver linings to the cloud…